Original Research

Page 55

Posts about this type

Original Research

Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Withdrawal Design

June 12, 2012

Matthew Brams, Richard Weisler, Robert L. Findling, et al

Original Research

Predictors of Placebo Response in Adults With Attention-Deficit/Hyperactivity Disorder: Data From 2 Randomized Trials of Osmotic-Release Oral System Methylphenidate

June 12, 2012

Jan K. Buitelaar, Esther Sobanski, Rolf-Dieter Stieglitz, et al

Original Research

Are Specific Symptoms of Depression Predictive of Alzheimer's Dementia?

May 29, 2012

Nilufar Mossaheb, Sonja Zehetmayer, Susanne Jungwirth, et al

Original Research

The Impact of Chronic Depression on Acute and Long-Term Outcomes in a Randomized Trial Comparing Selective Serotonin Reuptake Inhibitor Monotherapy Versus Each of 2 Different Antidepressant Medication Combinations

May 29, 2012

Sharon C. Sung, Charlotte L. Haley, Stephen R. Wisniewski, et al

Original Research

Leptin, Abdominal Obesity, and Onset of Depression in Older Men and Women

May 29, 2012

Yuri Milaneschi, Eleanor M. Simonsick, Nicole Vogelzangs, et al

Original Research

Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia: A 52-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

May 15, 2012

John M. Kane, Raymond Sanchez, Pamela P. Perry, et al

Original Research

Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder

May 15, 2012

David Mischoulon, Jonathan E. Alpert, Erland Arning, et al

Original Research

Cost and Cost-Effectiveness in a Randomized Trial of Long-Acting Risperidone for Schizophrenia

May 15, 2012

Paul G. Barnett, Jennifer Y. Scott, John H. Krystal, et al

Original Research

Effect of Tryptophan Hydroxylase Gene Polymorphism on Aggression in Major Depressive Disorder and Undifferentiated Somatoform Disorder

May 15, 2012

Kyung Bong Koh, Chan Hyung Kim, Eun Hee Choi, et al

Original Research

Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial

May 15, 2012

Richard S. E. Keefe, Sophia Vinogradov, Alice Medalia, et al

Original Research

A Longitudinal Investigation of the Role of Self-Medication in the Development of Comorbid Mood and Drug Use Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

May 15, 2012

Samuel Lazareck, Jennifer A. Robinson, Rosa M. Crum, et al

Original Research

A Longitudinal Study of Nonsuicidal Self-Injury in Offspring at High Risk for Mood Disorder

May 15, 2012

Lara J. Cox, Barbara H. Stanley, Nadine M. Melhem, et al

Original Research

Obesity Comorbidity in Unipolar Major Depressive Disorder: Refining the Core Phenotype

May 15, 2012

Robert D. Levitan, Caroline Davis, Allan S. Kaplan, et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder

May 15, 2012

Jill M. Williams, Robert M. Anthenelli, Chad D. Morris, et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for the Treatment of Apathy in Individuals With Mild-to-Moderate Alzheimer's Disease

May 15, 2012

Laura L. Frakey, Stephen Salloway, Melissa Buelow, et al

Original Research

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

May 15, 2012

Chi-Un Pae, J. Alexander Bodkin, Kimberly Blanchard Portland, et al

Original Research

The Renin-Angiotensin Pathway in Posttraumatic Stress Disorder: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Are Associated With Fewer Traumatic Stress Symptoms

May 1, 2012

Nayla M. Khoury, Paul J. Marvar, Charles F. Gillespie, et al

Original Research

Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?

April 17, 2012

Mark Zimmerman, Jennifer A. Martinez, Naureen Attiullah, et al

Original Research

Benzodiazepine Use Possibly Increases Cancer Risk: A Population-Based Retrospective Cohort Study in Taiwan

April 15, 2012

Chia-Hung Kao, Li-Min Sun, Kuan-Pin Su, et al

Original Research

Clinical Expression of Bipolar Disorder Type I as a Function of Age and Polarity at Onset: Convergent Findings in Samples From France and the United States

April 15, 2012

Bruno Etain, Mohamed Lajnef, Frank Bellivier, et al

Original Research

Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval in the United States: Results Observed With the First 100 Consecutive Cases of Depression at an Academic Medical Center

April 15, 2012

K. Ryan Connolly, Amanda Helmer, Mario A. Cristancho, et al

Original Research

Prescribed Medication Availability and Deliberate Self-Poisoning: A Longitudinal Study

April 15, 2012

Bergljot Gjelsvik, Fridtjof Heyerdahl, Keith Hawton

Original Research

Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years: A 3-Year Open-Label Clinical Study

April 15, 2012

Robin Emsley, Petrus P. Oosthuizen, Liezl Koen, et al

Original Research

Differences Among Major Depressive Disorder With and Without Co-occurring Substance Use Disorders and Substance-Induced Depressive Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

March 20, 2012

Carlos Blanco, Analucía A. Alegría, Shang-Min Liu, et al

« 1 … 53 54 55 56 57 … 157 »

Original Research

Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Withdrawal Design

Predictors of Placebo Response in Adults With Attention-Deficit/Hyperactivity Disorder: Data From 2 Randomized Trials of Osmotic-Release Oral System Methylphenidate

Are Specific Symptoms of Depression Predictive of Alzheimer's Dementia?

The Impact of Chronic Depression on Acute and Long-Term Outcomes in a Randomized Trial Comparing Selective Serotonin Reuptake Inhibitor Monotherapy Versus Each of 2 Different Antidepressant Medication Combinations

Leptin, Abdominal Obesity, and Onset of Depression in Older Men and Women

Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia: A 52-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder

Cost and Cost-Effectiveness in a Randomized Trial of Long-Acting Risperidone for Schizophrenia

Effect of Tryptophan Hydroxylase Gene Polymorphism on Aggression in Major Depressive Disorder and Undifferentiated Somatoform Disorder

Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial

A Longitudinal Investigation of the Role of Self-Medication in the Development of Comorbid Mood and Drug Use Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

A Longitudinal Study of Nonsuicidal Self-Injury in Offspring at High Risk for Mood Disorder

Obesity Comorbidity in Unipolar Major Depressive Disorder: Refining the Core Phenotype

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder

A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for the Treatment of Apathy in Individuals With Mild-to-Moderate Alzheimer's Disease

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

The Renin-Angiotensin Pathway in Posttraumatic Stress Disorder: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Are Associated With Fewer Traumatic Stress Symptoms

Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?

Benzodiazepine Use Possibly Increases Cancer Risk: A Population-Based Retrospective Cohort Study in Taiwan

Clinical Expression of Bipolar Disorder Type I as a Function of Age and Polarity at Onset: Convergent Findings in Samples From France and the United States

Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval in the United States: Results Observed With the First 100 Consecutive Cases of Depression at an Academic Medical Center

Prescribed Medication Availability and Deliberate Self-Poisoning: A Longitudinal Study

Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years: A 3-Year Open-Label Clinical Study

Differences Among Major Depressive Disorder With and Without Co-occurring Substance Use Disorders and Substance-Induced Depressive Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

ELSEWHERE:

FOLLOW US:

Original Research

Posts about this type

Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Withdrawal Design

Predictors of Placebo Response in Adults With Attention-Deficit/Hyperactivity Disorder: Data From 2 Randomized Trials of Osmotic-Release Oral System Methylphenidate

Are Specific Symptoms of Depression Predictive of Alzheimer's Dementia?

The Impact of Chronic Depression on Acute and Long-Term Outcomes in a Randomized Trial Comparing Selective Serotonin Reuptake Inhibitor Monotherapy Versus Each of 2 Different Antidepressant Medication Combinations

Leptin, Abdominal Obesity, and Onset of Depression in Older Men and Women

Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia: A 52-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder

Cost and Cost-Effectiveness in a Randomized Trial of Long-Acting Risperidone for Schizophrenia

Effect of Tryptophan Hydroxylase Gene Polymorphism on Aggression in Major Depressive Disorder and Undifferentiated Somatoform Disorder

Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial

A Longitudinal Investigation of the Role of Self-Medication in the Development of Comorbid Mood and Drug Use Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

A Longitudinal Study of Nonsuicidal Self-Injury in Offspring at High Risk for Mood Disorder

Obesity Comorbidity in Unipolar Major Depressive Disorder: Refining the Core Phenotype

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder

A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for the Treatment of Apathy in Individuals With Mild-to-Moderate Alzheimer's Disease

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

The Renin-Angiotensin Pathway in Posttraumatic Stress Disorder: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Are Associated With Fewer Traumatic Stress Symptoms

Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?

Benzodiazepine Use Possibly Increases Cancer Risk: A Population-Based Retrospective Cohort Study in Taiwan

Clinical Expression of Bipolar Disorder Type I as a Function of Age and Polarity at Onset: Convergent Findings in Samples From France and the United States

Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval in the United States: Results Observed With the First 100 Consecutive Cases of Depression at an Academic Medical Center

Prescribed Medication Availability and Deliberate Self-Poisoning: A Longitudinal Study

Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years: A 3-Year Open-Label Clinical Study

Differences Among Major Depressive Disorder With and Without Co-occurring Substance Use Disorders and Substance-Induced Depressive Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles